Profound Medical Corp.
PROF
$6.19
-$0.11-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 200.49% | 88.15% | |||
| Total Other Revenue | -43.38% | 160.47% | |||
| Total Revenue | 13.01% | 139.21% | |||
| Cost of Revenue | 46.24% | 129.01% | |||
| Gross Profit | 1.53% | 142.95% | |||
| SG&A Expenses | -4.55% | -20.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.03% | -11.33% | |||
| Operating Income | 17.32% | 35.44% | |||
| Income Before Tax | -3.73% | 49.74% | |||
| Income Tax Expenses | -78.51% | 89.06% | |||
| Earnings from Continuing Operations | -2.48% | 49.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.48% | 49.17% | |||
| EBIT | 17.32% | 35.44% | |||
| EBITDA | 17.18% | 35.85% | |||
| EPS Basic | -0.91% | 49.25% | |||
| Normalized Basic EPS | -2.15% | 49.83% | |||
| EPS Diluted | -0.91% | 49.25% | |||
| Normalized Diluted EPS | -2.15% | 49.83% | |||
| Average Basic Shares Outstanding | 1.56% | 0.17% | |||
| Average Diluted Shares Outstanding | 1.56% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||